Oteseconazole: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Oteseconazole. Educational only — not medical advice.

Labeled uses

VIVJOA™ is an azole antifungal indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential. ( 1 )

Source: FDA labeling via NIH DailyMed (set e21d5008…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.